Evidence map›Paper›PMID 32327486›Full record

ArticleThe Journal of biological chemistry2020

Sphingosine kills bacteria by binding to cardiolipin.

Rabea Verhaegh, Katrin Anne Becker, Michael J Edwards, Erich Gulbins

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Sphingosine synergizes with polymyxin antibiotics againstMicrobiology (Reading, England) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. mBio · 2025
    Article
  8. Sphingosine kills Mycobacteria and suppresses mycobacterial lung infections.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  9. Sphingosine-mediated death ofInfection and immunity · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. TheMicrobiology (Reading, England) · 2025
    Article
  14. ThebioRxiv : the preprint server for biology · 2024
    Article
  15. Article
  16. Article
  17. Sphingosine Prevents Rhinoviral Infections.International journal of molecular sciences · 2024
    Article
  18. Article
  19. Unleashing AdipoRon's Potential: A Fresh Approach to TackleJournal of inflammation research · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rabea VerhaeghDepartment of Molecular Biology, University Clinic, University of Duisburg-Essen, Essen, Germany.
Katrin Anne BeckerDepartment of Molecular Biology, University Clinic, University of Duisburg-Essen, Essen, Germany.
Michael J EdwardsDepartment of Surgery, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Erich GulbinsDepartment of Molecular Biology, University Clinic, University of Duisburg-Essen, Essen, Germany erich.gulbins@uni-due.de.
University of Cincinnati Medical Center · USUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingosine is a long-chain sphingoid base that has been shown to have bactericidal activity against many pathogens, including

Indexed as

Anti-Bacterial AgentsCardiolipinsCell MembraneEscherichia coliPseudomonas aeruginosaSphingosineStaphylococcus aureusAnti-Bacterial AgentsCardiolipinsSphingosinebactericidal activitycardiolipininnate immunitylung pathogenmembrane permeabilizationPseudomonas aeruginosa (P. aeruginosa)sphingoid basesphingolipidsphingosineStaphylococcus aureus (S. aureus)

Identifiers

PMID32327486
PMCPMC7261797
OpenAlexW3018474113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.